{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:05:13Z","timestamp":1769756713936,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chilblains have emerged as a cutaneous manifestation following coronavirus disease 2019 vaccination. While there are many case reports on chilblain-like lesions, documentation from tropical countries remains limited. In this context, we report a case detailing chilblain-like lesions associated with coronavirus disease 2019 vaccination in Thailand.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 35-year-old Thai female patient presented with several painful, red papules on the fingers and toes 9\u00a0days after receiving the mRNA-1273 vaccination. Skin biopsy was performed, and the results were consistent with chilblains. Laboratory workup revealed positive result for lupus anticoagulant. The rash completely resolved without any treatment but reappeared following the second vaccine dose.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Chilblain-like lesion following coronavirus disease 2019 vaccination is frequently observed in temperate countries, with few reports from tropical areas. The presence of lupus anticoagulant may contribute to the development of chilblains after coronavirus disease 2019 vaccination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13256-025-05254-7","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:22:11Z","timestamp":1746602531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chilblain-like lesion associated with coronavirus disease 2019 vaccine in tropical country: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Wasuchon","family":"Chaichan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mati","family":"Chuamanochan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pongsak","family":"Mahanupab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Chiewchanvit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9463-5976","authenticated-orcid":false,"given":"Napatra","family":"Tovanabutra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"12","key":"5254_CR1","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.amjmed.2009.07.011","volume":"122","author":"S Prakash","year":"2009","unstructured":"Prakash S, Weisman MH. Idiopathic chilblains. Am J Med. 2009;122(12):1152\u20135. https:\/\/doi.org\/10.1016\/j.amjmed.2009.07.011.","journal-title":"Am J Med"},{"issue":"2","key":"5254_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/bjd.20404","volume":"185","author":"S Lopez","year":"2021","unstructured":"Lopez S, Vakharia P, Vandergriff T, Freeman EE, Vasquez R. Pernio after COVID-19 vaccination. Br J Dermatol. 2021;185(2):445\u20137. https:\/\/doi.org\/10.1111\/bjd.20404.","journal-title":"Br J Dermatol"},{"issue":"6","key":"5254_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1067\/mjd.2001.117861","volume":"45","author":"B Cribier","year":"2001","unstructured":"Cribier B, Djeridi N, Peltre B, Grosshans E. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol. 2001;45(6):924\u20139. https:\/\/doi.org\/10.1067\/mjd.2001.117861.","journal-title":"J Am Acad Dermatol"},{"key":"5254_CR4","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3888","author":"K Souaid","year":"2021","unstructured":"Souaid K, Oul\u00e8s B, Sohier P, Deschamps L, Aractingi S, Dupin N. Type I interferon signature in chilblains following SARS-CoV-2 mRNA vaccine: a case report. Acta Derm-Venereol. 2021. https:\/\/doi.org\/10.2340\/00015555-3888.","journal-title":"Acta Derm-Venereol"},{"issue":"4","key":"5254_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.mayocp.2021.01.009","volume":"96","author":"MA Cappel","year":"2021","unstructured":"Cappel MA, Cappel JA, Wetter DA. Pernio (Chilblains), SARS-CoV-2, and COVID toes unified through cutaneous and systemic mechanisms. Mayo Clin Proc. 2021;96(4):989\u20131005. https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.009.","journal-title":"Mayo Clin Proc"},{"key":"5254_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2019.00487","volume":"10","author":"E Palli","year":"2019","unstructured":"Palli E, Kravvariti E, Tektonidou MG. Type I interferon signature in primary antiphospholipid syndrome: clinical and laboratory associations. Front Immunol. 2019;10:487. https:\/\/doi.org\/10.3389\/fimmu.2019.00487.","journal-title":"Front Immunol"},{"issue":"3","key":"5254_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/ard.52.3.219","volume":"52","author":"L Naldi","year":"1993","unstructured":"Naldi L, Locati F, Marchesi L, Cortelazzo S, Finazzi G, Galli M, Brevi A, Cainelli T, Barbui T. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis. 1993;52(3):219\u201322. https:\/\/doi.org\/10.1136\/ard.52.3.219.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5254_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/s0046-8177(97)90038-1","volume":"28","author":"AN Crowson","year":"1997","unstructured":"Crowson AN, Magro CM. Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases. Hum Pathol. 1997;28(4):478\u201384. https:\/\/doi.org\/10.1016\/s0046-8177(97)90038-1.","journal-title":"Hum Pathol"},{"issue":"3","key":"5254_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.2010.09829.x","volume":"163","author":"V Lutz","year":"2010","unstructured":"Lutz V, Cribier B, Lipsker D. Chilblains and antiphospholipid antibodies: report of four cases and review of the literature. Br J Dermatol. 2010;163(3):645\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09829.x.","journal-title":"Br J Dermatol"},{"issue":"24","key":"5254_CR10","doi-asserted-by":"publisher","first-page":"03217","DOI":"10.1016\/j.jaad.2024.11.014","volume":"S0190\u20139622","author":"JS Arora","year":"2024","unstructured":"Arora JS, Kesler A, Min MS. A global retrospective study identifies higher rates of pernio in individuals with connective tissue disease. J Am Acad Dermatol. 2024;S0190\u20139622(24):03217\u201321. https:\/\/doi.org\/10.1016\/j.jaad.2024.11.014.","journal-title":"J Am Acad Dermatol"},{"issue":"570","key":"5254_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd3876","volume":"12","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, Sule G, Gockman K, Madison JA, Zuo M, Yadav V, Wang J, Woodard W, Lezak SP, Lugogo NL, Smith SA, Morrissey JH, Kanthi Y, Knight JS. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570): eabd3876. https:\/\/doi.org\/10.1126\/scitranslmed.abd3876.","journal-title":"Sci Transl Med"},{"issue":"1","key":"5254_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11239-020-02335-w","volume":"52","author":"C Gazzaruso","year":"2021","unstructured":"Gazzaruso C, Mariani G, Ravetto C, Malinverni L, Tondelli E, Cerrone M, Sala V, Bevilacqua L, Altavilla T, Coppola A, Gallotti P. Lupus anticoagulant and mortality in patients hospitalized for COVID-19. J Thromb Thrombolysis. 2021;52(1):85\u201391. https:\/\/doi.org\/10.1007\/s11239-020-02335-w.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"5254_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13104-022-06180-3","volume":"15","author":"G Krashias","year":"2022","unstructured":"Krashias G, Pafiti A, Deeba E, Christodoulou C, Pantzaris M, Lambrianides A. SARS CoV- 2 vaccination induces antibodies against cardiolipin. BMC Res Notes. 2022;15(1):292. https:\/\/doi.org\/10.1186\/s13104-022-06180-3.","journal-title":"BMC Res Notes"},{"issue":"11","key":"5254_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3899\/jrheum.220487","volume":"49","author":"A Karamanakos","year":"2022","unstructured":"Karamanakos A, Evangelatos G, Pappa M, Fragiadaki K, Fanouriakis A, Fragoulis GE. Chilblains after SARS-CoV-2 vaccination: coincidence or real association? J Rheumatol. 2022;49(11):1295\u20136. https:\/\/doi.org\/10.3899\/jrheum.220487.","journal-title":"J Rheumatol"},{"issue":"9","key":"5254_CR15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1111\/jth.14994","volume":"18","author":"KMJ Devreese","year":"2020","unstructured":"Devreese KMJ, Linskens EA, Benoit D, Peperstraete H. Antiphospholipid antibodies in patients with COVID-19: a relevant observation? J Thromb Haemost. 2020;18(9):2191\u2013201. https:\/\/doi.org\/10.1111\/jth.14994.","journal-title":"J Thromb Haemost"},{"key":"5254_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cytogfr.2021.05.001","volume":"60","author":"R Talotta","year":"2021","unstructured":"Talotta R, Robertson ES. Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: the straw that breaks the camel\u2019s back? Cytokine Growth Factor Rev. 2021;60:52\u201360. https:\/\/doi.org\/10.1016\/j.cytogfr.2021.05.001.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"5254_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","volume":"23","author":"JY Dabit","year":"2022","unstructured":"Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-Garc\u00eda A. epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep. 2022;23(12):85. https:\/\/doi.org\/10.1007\/s11926-021-01038-2.","journal-title":"Curr Rheumatol Rep"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05254-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05254-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05254-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:22:11Z","timestamp":1746602531000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05254-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5254"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05254-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for publication was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}